Replimune Group, Inc. (REPL) Misses Q2 EPS by 9c

Replimune Group, Inc. (NASDAQ: REPL) reported Q2 EPS of ($0.90), $0.09 worse than the analyst estimate of ($0.81).

For earnings history and earnings-related data on Replimune Group, Inc. (REPL) click here.

You May Also Be Interested In

• Morgan Stanley upgrades CDW on stronger AI-driven server demand
• Piper Sandler on Fervo Energy (FRVO): 'Capital Access Supports Potential Upside'
• Goldman "broadly" raises estimates for LTL and truckload stocks